The mitochondrial citrate transport protein (CTP) has been investigated by replacing 22 consecutive residues within transmembrane domain IV, one at a time, with cysteine. A cysteine-less CTP retaining wild-type functional properties served as the starting template. The single Cys CTP variants were overexpressed in Escherichia coli, isolated, and functionally reconstituted in a liposomal system. The accessibility of each single Cys mutant to three methanethiosulfonate reagents was evaluated by determining the pseudo first order rate constants for inhibition of CTP function. These rate constants varied by seven orders of magnitude. With three independent data sets we observed peaks and troughs in the rate constant data at identical amino acid positions and a periodicity of four was observed from residues 177-193. Based on the pattern of accessibility we conclude that residues 177-193 exist as an ␣-helix. The citrate transport protein (i.e. CTP) 1 from mammalian mitochondria catalyzes an electroneutral exchange across the inner mitochondrial membrane of a tricarboxylate (i.e. citrate, isocitrate, cis-aconitate) plus a proton, for either another tricarboxylate-H ϩ , a dicarboxylate (i.e. malate, succinate), or phosphoenolpyruvate (1). Following the efflux of citrate from the mitochondrial matrix via the CTP, cytoplasmic citrate serves as both a carbon precursor for the fatty acid and the sterol biosynthetic pathways, as well as a source of NAD ϩ (via the concerted actions of ATP-citrate lyase and malate dehydrogenase) for the glycolytic pathway (2-5). Because of the central role of the CTP in higher eukaryotic metabolism, the transporter has been extensively studied. Thus, it has been purified (6, 7), kinetically characterized (8), cloned (9), and overexpressed (10). More recently we have extended our studies of the CTP to the yeast homologue of the higher eukaryotic protein (11). An advantage afforded by the yeast mitochondrial CTP is that following overexpression in Escherichia coli and subsequent isolation, CTP function can be reconstituted with high specific activity. Thus, the yeast CTP represents ideal material with which to conduct a comprehensive structure/function analysis. With this goal in mind, we recently constructed a Cys-less CTP that displays near native functional properties. Moreover, we have demonstrated that upon isolation, both the isolated wild-type and Cys-less CTPs exist as functional dimers.3 Based on hydropathy analysis, each monomer of the homodimer is predicted to contain six membrane-spanning domains (11).Within the CTP, transmembrane domain IV (i.e. TMDIV) is of particular interest for several reasons. First, this domain contains two arginine residues (Arg-181 and -189). We have previously demonstrated that CTP function requires the presence of positive charge at both sites.2 Second, TMDIV can be modeled as an ␣-helix with both arginines residing on the same face of the helix, thereby providing a polar domain, which might conceivably be accessible to citrate and provide a partial neutra...